1. De Mattia, Elena, Polesel, Jerry, Silvestri, Marco, Toffoli, Giuseppe, Cecchin, Erika. 2023. The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity. In Human genomics, 17, 99. doi:10.1186/s40246-023-00546-9. https://pubmed.ncbi.nlm.nih.gov/37946254/
2. Yokoi, Katsuyuki, Nakajima, Yoko, Matsuoka, Hiroshi, Ito, Tetsuya, Kurahashi, Hiroki. 2020. Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer. In Cancer science, 111, 3359-3366. doi:10.1111/cas.14553. https://pubmed.ncbi.nlm.nih.gov/32619063/
3. Li, Jiaqing, Xu, Sanqing. . Juvenile Parkinsonism Associated With Dihydropyrimidinase Deficiency. In Pediatrics, 154, . doi:10.1542/peds.2024-068477. https://pubmed.ncbi.nlm.nih.gov/39558747/
4. Hishinuma, Eiji, Akai, Fumika, Narita, Yoko, Hirasawa, Noriyasu, Hiratsuka, Masahiro. 2017. Functional characterization of 21 allelic variants of dihydropyrimidinase. In Biochemical pharmacology, 143, 118-128. doi:10.1016/j.bcp.2017.06.121. https://pubmed.ncbi.nlm.nih.gov/28642038/
5. Nakajima, Yoko, Meijer, Judith, Dobritzsch, Doreen, Zoetekouw, Lida, van Kuilenburg, André B P. 2017. Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity. In Molecular genetics and metabolism, 122, 216-222. doi:10.1016/j.ymgme.2017.10.003. https://pubmed.ncbi.nlm.nih.gov/29054612/